Infectocure  125 mg / 5 ml powder for oral suspension is indicated in adolescents and children, 6 months to 12 years, for the treatment of the following acute and chronic infections, when caused by clarithromycin susceptible organisms-Infections of the upper respiratory tract such as tonsillitis/pharyngitis, Acute otitis media in children-Infections of the lower respiratory tract such as community acquired pneumonia-Sinusitis and acute exacerbation of chronic bronchitis -Skin infections and soft tissue infections of mild to moderate severity-for the eradication of Helicobacter pylori